Orally Disintegrating Tablets: Guidance for Industry. U.S. Food and Drug Administration. https://www.fda.gov/media/70877/download. Date Accessed August 6, 2026.
Quality Attribute Considerations for Chewable Tablets: Guidance for Industry. U.S. Food and Drug Administration. https://www.fda.gov/files/drugs/published/Quality-Attribute-Considerations-for-Chewable-Tablets-Guidance-for-Industry.pdf. Date Accessed August 6, 2026.
Ondansetron Orally Disintegrating Tablets: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cab63f24-8728-4927-aba5-53e8d2e44cdb. Date Accessed August 6, 2026.
Olanzapine Orally Disintegrating Tablets: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd0b2525-4e2f-44fc-9302-0ae4ebb1e135. Date Accessed August 6, 2026.
MAXALT-MLT (Rizatriptan Benzoate Orally Disintegrating Tablets): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=007b4644-e0e7-4863-9ae3-fe09676b3f5f. Date Accessed August 6, 2026.